In fact, using an innovative high-throughput technology, we discovered that several biological elements involved in the oxidative phosphorylation system (OXPHOS) and two key constituents of the mitochondrial complex IV (COXI and COXIV) were deregulated in CKD and HD patients compared to the healthy controls. The gene discussed is COX4I1; the disease is Huntington disease.